$27.90
1.194.46%
At close: -
$28.00
0.100.36%
After Hours: Apr 11, 6:08 PM EDT
Comments
Loading...
Ionis Pharmaceuticals Stock Guidance | NASDAQ:IONS | Benzinga
Ionis Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/19/2025 | IONS | Ionis Pharmaceuticals | FY | 2025 | — | — | — | $600.00M | — | $677.05M | Get Alert |
| 11/06/2024 | IONS | Ionis Pharmaceuticals | FY | 2024 | — | — | — | $575.00M | — | $623.90M | Get Alert |
| 08/01/2024 | IONS | Ionis Pharmaceuticals | FY | 2024 | — | — | — | $575.00M | — | $608.71M | Get Alert |
| 05/07/2024 | IONS | Ionis Pharmaceuticals | FY | 2024 | — | — | — | $575.00M | — | $618.12M | Get Alert |
| 02/21/2024 | IONS | Ionis Pharmaceuticals | FY | 2024 | — | — | — | $575.00M | — | $636.36M | Get Alert |
| 11/02/2023 | IONS | Ionis Pharmaceuticals | FY | 2023 | — | — | — | $575.00M | — | $620.05M | Get Alert |
| 08/09/2023 | IONS | Ionis Pharmaceuticals | FY | 2023 | — | — | — | $575.00M | — | $586.28M | Get Alert |
| 05/03/2023 | IONS | Ionis Pharmaceuticals | FY | 2023 | — | — | — | $575.00M | — | $597.65M | Get Alert |
| 02/22/2023 | IONS | Ionis Pharmaceuticals | FY | 2023 | — | — | — | $575.00M | — | $672.18M | Get Alert |
| 11/09/2022 | IONS | Ionis Pharmaceuticals | FY | 2022 | — | — | — | $575.00M | — | $594.45M | Get Alert |
| 08/09/2022 | IONS | Ionis Pharmaceuticals | FY | 2022 | — | — | — | $575.00M | — | $610.05M | Get Alert |
| 05/04/2022 | IONS | Ionis Pharmaceuticals | FY | 2022 | — | — | — | $575.00M | — | $612.37M | Get Alert |
| 02/24/2022 | IONS | Ionis Pharmaceuticals | FY | 2022 | — | — | — | $575.00M | — | $648.72M | Get Alert |
| 08/04/2021 | IONS | Ionis Pharmaceuticals | FY | 2021 | — | — | — | $600.00M | — | $618.55M | Get Alert |
| 05/05/2021 | IONS | Ionis Pharmaceuticals | FY | 2021 | — | — | — | $600.00M | — | $632.68M | Get Alert |
| 02/24/2021 | IONS | Ionis Pharmaceuticals | FY | 2021 | — | — | — | $600.00M | — | $781.31M | Get Alert |
FAQ
What is the most recent guidance for Ionis Pharmaceuticals (IONS)?
There have been no specific sales or earnings guidance reported for Ionis Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.